| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/12/2011 | CA2779935A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors |
| 05/12/2011 | CA2779642A1 Enzyme inhibiting compounds |
| 05/12/2011 | CA2779574A1 Novel kinase modulators |
| 05/12/2011 | CA2779423A1 Benzodiazepine bromodomain inhibitor |
| 05/12/2011 | CA2779355A1 Benzodiazepine bromodomain inhibitor |
| 05/12/2011 | CA2778940A1 Process for the preparation of imidazo[2,1-b][1,3]benzothiazole derivatives |
| 05/12/2011 | CA2778552A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | CA2778115A1 Imidazole derivatives as ido inhibitors |
| 05/11/2011 | EP2319935A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/11/2011 | EP2319934A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/11/2011 | EP2319873A1 Dextran for treating lung cancer |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319850A1 Optically active -amino acid into which bsh is introduced and method for synthesizing the same |
| 05/11/2011 | EP2319849A1 Method for producing bsh derivative and bsh derivative |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319541A1 Factor VII or VIIA-like conjugates |
| 05/11/2011 | EP2319536A1 Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer |
| 05/11/2011 | EP2319535A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 05/11/2011 | EP2319533A1 Immunity-inducing agent and method for detection of cancer |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2319519A1 Composition for inhibiting expression of target gene |
| 05/11/2011 | EP2318440A1 Antibodies binding to adrenomedullin receptors and uses thereof as drugs |
| 05/11/2011 | EP2318438A1 Anti-p2x7 peptiden und epitopen |
| 05/11/2011 | EP2318419A1 Boronate ester compounds and pharmaceutical compositions thereof |
| 05/11/2011 | EP2318415A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 05/11/2011 | EP2318414A2 Imidazo [1,2-a] pyrimidine derivatives, process for their preparation, use as medicaments, pharmaceutical compositions and use as met inhibitors |
| 05/11/2011 | EP2318413A1 Pyrrolobenzodiazepines |
| 05/11/2011 | EP2318408A2 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 05/11/2011 | EP2318407A1 Pyrazolopyridine kinase inhibitors |
| 05/11/2011 | EP2318406A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 05/11/2011 | EP2318401A2 Azaindole inhibitors of iap |
| 05/11/2011 | EP2318400A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
| 05/11/2011 | EP2318395A2 Inhibitors of iap |
| 05/11/2011 | EP2318393A1 Novel polymorphs of sunitinib and processes for their preparation |
| 05/11/2011 | EP2318392A2 Pyrimidine derivatives as kinase inhibitors |
| 05/11/2011 | EP2318389A1 Pyridazine derivatives as smo inhibitors |
| 05/11/2011 | EP2318382A1 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 05/11/2011 | EP2318369A1 Squaric acid derivatives as inhibitors of the nicotinamide |
| 05/11/2011 | EP2318366A2 Psma-binding agents and uses thereof |
| 05/11/2011 | EP2318363A1 Heterocyclic derivatives as iap binding compounds |
| 05/11/2011 | EP2318361A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/11/2011 | EP2318042A1 Vaccine against hpv |
| 05/11/2011 | EP2318040A1 Therapy targeting cancer stem cells |
| 05/11/2011 | EP2318027A2 Isolation of cyclopamine |
| 05/11/2011 | EP2318015A1 Treatment of cancers of the blood using selected glycomimetic compounds |
| 05/11/2011 | EP2318013A1 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
| 05/11/2011 | EP2318009A1 9-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer |
| 05/11/2011 | EP2318007A1 Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents |
| 05/11/2011 | EP2318002A2 Use of mtor inhibitors to enhance t cell immune responses |
| 05/11/2011 | EP2318000A1 Anti-tumoural effects of cannabinoid combinations |
| 05/11/2011 | EP2317999A2 Methods for modulating angiogenesis via dystrophin dp71 |
| 05/11/2011 | EP1910375B1 Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors |
| 05/11/2011 | EP1803811B1 Chimeric (double) decoy |
| 05/11/2011 | EP1604665B1 C-kit kinase inhibitor |
| 05/11/2011 | EP1449850B9 Human cdr-grafted antibodies and antibody fragments thereof |
| 05/11/2011 | EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/11/2011 | EP1381280B1 Viral vectors and their use in therapeutic methods |
| 05/11/2011 | EP1163262B1 Phenylalanine derivatives |
| 05/11/2011 | EP1001755B1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/11/2011 | CN1931869B Derivative of 5-deoxy-5-fluoro cytidine and its preparation process and use |
| 05/11/2011 | CN1899614B Preparation for the prophylaxis of restenosis |
| 05/11/2011 | CN1895237B Officinal magnolia phenol lipid frozen dried powder preparation and its use in preparing drug for cancers |
| 05/11/2011 | CN1852740B Multi-arm polymer prodrugs |
| 05/11/2011 | CN1786003B Sulfur, nitrogen heterocyclic naphacyl imine cell compounds and its application in tumour cell |
| 05/11/2011 | CN1599623B Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 05/11/2011 | CN102056939A Restoration of estrogen receptor-alpha activity |
| 05/11/2011 | CN102056930A Halichondrin B analogs |
| 05/11/2011 | CN102056926A Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 05/11/2011 | CN102056925A Compounds and compositions as kinase inhibitors |
| 05/11/2011 | CN102056905A Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof |
| 05/11/2011 | CN102056631A Apoptosis inducer |
| 05/11/2011 | CN102056628A Inorganic nanoparticles, preparation and uses thereof |
| 05/11/2011 | CN102056622A Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| 05/11/2011 | CN102056616A TPO mimetic peptide for preventing hematological disorder associated with cancer treatment |
| 05/11/2011 | CN102056609A Pharmaceutical combination |
| 05/11/2011 | CN102056589A Solid pharmaceutical formulations comprising BIBW 2992 |
| 05/11/2011 | CN102051394A Preparation method and application of sulfo-diketopiperazine compounds |
| 05/11/2011 | CN102051362A Interference RNA (Ribonucleic Acid) of targeted HPIP (hematopoietic PBX-interacting protein) gene, medical composition containing same and application thereof |
| 05/11/2011 | CN102051361A Small interfering ribonucleic acid (siRNA) for inhibiting human AE1 gene expression, expression plasmid thereof, and application thereof to pharmacy |
| 05/11/2011 | CN102051358A Mosaic tumor specific gene expression regulation kit and application thereof |
| 05/11/2011 | CN102051016A Degradable amphiphilic triblock copolymer micelle and preparation method and application of degradable amphiphilic triblock copolymer micelle |
| 05/11/2011 | CN102050879A Anti-human CD20 humanized antibody and preparation method and application thereof |
| 05/11/2011 | CN102050878A Anti-human CD20 humanized antibody and preparation method and application thereof |
| 05/11/2011 | CN102050877A Anti-human CD20 humanized antibody, preparation method and application thereof |
| 05/11/2011 | CN102050867A Tetrapeptide analog, preparation method and application thereof |
| 05/11/2011 | CN102050862A New honeysuckle chlorogenic acid ester saponin as well as preparation method and use thereof |
| 05/11/2011 | CN102050856A High-activity epirubicin derivative, preparation method thereof and application thereof |
| 05/11/2011 | CN102050838A Sulfoxide isothiocyanicacid alkane metal complexing compound and application thereof |
| 05/11/2011 | CN102050832A Melonines bisindole compound, medicine composition, preparation method and application thereof |
| 05/11/2011 | CN102050821A Novel imidazo(1,5-a)pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/11/2011 | CN102050793A 4(3H) quinazolinone derivatives with antitumor activity |
| 05/11/2011 | CN102050770A Sulfoxide-based alkane isothiocyanate optical isomer and application thereof in preparation of drugs |
| 05/11/2011 | CN102050759A Resveratrol amide derivative and preparation method thereof |
| 05/11/2011 | CN102050755A Novel agomelatine crystal forms and preparation methods of agomelatine crystal forms |
| 05/11/2011 | CN102050733A Biphenyl cyclooctene type lignan compound and medicinal application thereof |
| 05/11/2011 | CN102050703A Resveratrol derivate as well as preparation method and application thereof |
| 05/11/2011 | CN102049039A Application of p65 in preparation of medicament for up-regulating SIRT1 expression |
| 05/11/2011 | CN102049038A Application of gelatinase A inhibitory polypeptide modifier |
| 05/11/2011 | CN102048987A Traditional Chinese medicine composition for treating acute myeloblastic leukemia (AML) M3 |